Sientra And Its Advisors Continue To Find Ways To Improve The Company's Balance Sheet And, Together With Its Financial Partners, Are Exploring Strategic Alternatives To Provide The Strongest Path Forward For Continued Success

Sientra, Inc. 0.00% Pre




0.00% Pre

Sientra and its advisors continue to find ways to improve the Company's balance sheet and, together with its financial partners, are exploring strategic alternatives to provide the strongest path forward for continued success. Throughout this process, it remains business as usual and Sientra will continue to deliver for its customers, patients, employees, and partners seamlessly.

"We remain focused on delivering the safest and most innovative solutions for the best aesthetic outcomes," said Ron Menezes, President and CEO of Sientra. "While we continue to see softness in the augmentation market, we are encouraged by our growth in breast reconstruction as we gain momentum from new products such as Viality and SimpliDerm. We are also committed to enhancing our financial footing to position Sientra as a partner of choice for plastic surgeons."

Every question you ask will be answered
Scan the QR code to contact us
Also you can contact us via